|4May 29, 4:17 PM ET

FitzPatrick Margaret M 4

4 · AN2 Therapeutics, Inc. · Filed May 29, 2025

Insider Transaction Report

Form 4
Period: 2025-05-28
Transactions
  • Purchase

    Common Stock

    2025-05-28$1.18/sh+8,610$10,1338,610 total
Footnotes (1)
  • [F1]This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.17 to $1.18 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4